Biologics, biosimilars, and biobetters : an introduction for pharmacists, physicians, and other health practitioners /
"Biologics (and their interchangeable equivalents, biosimilars) and their more efficacious successors (biobetters) are taking up a larger share of the therapeutics drug market compared to small molecule drugs. They are potent, more expensive, and complex in their therapeutic and clinical utilit...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Hoboken, NJ :
Wiley,
2021.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Innovator Biologics, Biosimilars and Biobetters : Terminology, Nomenclature and Definitions
- Approved Biologic Medicines and Biosimilars in Major Regulatory Jurisdictions
- Status of Biologic Drugs in Modern Therapeutics-Targeted Therapies vs Small Molecule Drugs
- Major Classes of Biotherapeutics
- Drug Targets for Biologics
- Pivotal Biology, Chemistry, Biochemistry and Biophysical Concepts of Biologics and Biosimilars
- Biosimilarity and Interchangeability of Biologic Drugs- General Principles, Biophysical Tests and Clinical Requirements to Demonstrate Biosimilarity
- Pharmacokinetics of Biologics
- Pharmacogenomics of Biologics
- International Regulatory Processes and Policies for Innovator Biologics, Biosimilars and Biobetters
- Pharmacovigilance of Innovator Biologics and Biosimilars
- Pharmacoeconomics of Biologic Medicines and Biosimilars / Gregory Reardon
- New Emerging Biotherapies : Cutting-Edge Research to Experimental Therapies
- Optimising Use of Biologic Medicines Using a Quality Use of Medicines Approach
- Knowledge Areas and Competency Standards on Biologic Medicines for Pharmacists and Pharmacy Students
- A Checklist for Pharmacists on Biologics and Biosimilars
- Tips to Enhance Patient-Centred Discussions.